alifedrine

01/01/1988 - "A randomized, double-blind, double-crossover, placebo-controlled haemodynamic study was undertaken in patients with Grade II/III (NYHA) cardiac failure to examine the acute effects of intravenous alifedrine, 20 mg and 40 mg (17 patients), and oral 40 mg alifedrine (8 of these patients). "
01/01/1989 - "Alifedrine may have a place in the treatment of heart failure as an oral by active, positive inotropic agent."
01/01/1989 - "The haemodynamic effects of single oral doses of alifedrine 40 mg, 50 mg, 60 mg and placebo were compared in 30 patients with mild to moderate heart failure. "
01/01/1989 - "Acute haemodynamic effects of different doses of alifedrine in congestive heart failure."
01/01/1988 - "Haemodynamic effects of intravenous and oral alifedrine in patients with cardiac failure."

03/15/1988 - "Following release of a 40 min coronary artery occlusion there was a marked reduction in reperfusion-induced ventricular fibrillation from 75% in controls, to 37% in the alifedrine-treated dogs. "